US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 4.895
  • -0.025-0.51%
Trading Mar 21 12:03 ET
221.34MMarket Cap-7.31P/E (TTM)

About Y-mAbs Therapeutics Company

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.

Company Profile

SymbolYMAB
Company NameY-mAbs Therapeutics
Listing DateSep 21, 2018
Issue Price16.00
Founded2015
CEOMr. Michael Rossi
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address202 Carnegie Center,Suite 301
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-646-885-8505
Websitehttp://www.ymabs.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Rossi
  • Director, President and Chief Executive Officer
  • 3.11M
  • Vignesh Rajah
  • Senior Vice President and Chief Medical Officer
  • --
  • Dr. Torben Lund-Hansen, PhD
  • Senior Vice President and Chief Technical Officer
  • --
  • Peter P. Pfreundschuh
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • --
  • Sue Smith
  • Senior Vice President and Chief Commercial Officer
  • 887.28K
  • Thomas Gad
  • Vice Chairman of the Board and Chief Business Officer
  • 2.45M
  • Joris Wiel Jan Wilms
  • Senior Vice President and Chief Operating Officer
  • --
  • Dr. Steen Lisby
  • Senior Vice President and Chief Scientific Officer
  • --
  • Doug Gentilcore
  • Senior Vice President, Danyelza Business
  • --
  • Natalie Tucker
  • Senior Vice President, Radiopharmaceutical Business Head
  • --
  • Dr. James I. Healy, M.D.,PhD
  • Chairman of the Board
  • 184.31K
  • Dr. Mary A. Tagliaferri, M.D.
  • Director
  • --
  • David N. Gill
  • Independent Director
  • 180.56K
  • Laura J. Hamill
  • Independent Director
  • 168.06K
  • Johan Wedell-Wedellsborg
  • Independent Director
  • 158.06K
  • Dr. Ashutosh Tyagi, M.D.
  • Independent Director
  • 158.06K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Guangdong Xinyaguang Cable
001382
+304.19%
Haimo Technologies Group Corp.
300084
+20.03%
Shaoyang Victor Hydraulics
301079
+19.98%
4
KLT
831689
+19.93%
5
Qingdao Tianneng Heavy Industries
300569
+19.92%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call